Cardiac surgery for a patient with familial lecithin: cholesterol acyltransferase deficiency

Jpn J Thorac Cardiovasc Surg. 2005 Jun;53(6):317-9. doi: 10.1007/s11748-005-0136-1.

Abstract

A 62-year-old female with familial lecithin: cholesterol acyltransferase (LCAT) deficiency was subjected to cardiac surgery consisting of mitral valve repair, tricuspid valve annuloplasty, and left atrium plication, under cardiopulmonary bypass. Familial LCAT deficiency is a very rare disease with clinical features including corneal opacity, hemolytic anemia, and renal failure. Our patient manifests partial LCAT activity and no renal failure. Patients with LCAT deficiency have fragile red blood cells, renal dysfunction, and disturbed metabolism of platelet-activating factor. To date, no record of cardiac surgery on patients with LCAT deficiency has been reported. Thus, we present the result of this experience to share what we learned about this complicated and rare disease.

Publication types

  • Case Reports

MeSH terms

  • Cardiopulmonary Bypass*
  • Female
  • Heart Atria / surgery*
  • Heart Valve Diseases / surgery*
  • Humans
  • Lecithin Cholesterol Acyltransferase Deficiency / complications*
  • Middle Aged